e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Biomarkers in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients.
L. Bryant (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), A. Yousuf (Leicester, United Kingdom), R. Cordell (Leicester, United Kingdom), M. Wilde (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), P. Monks (Leicester, United Kingdom)
Source:
International Congress 2018 – Biomarkers in COPD and asthma
Session:
Biomarkers in COPD and asthma
Session type:
Oral Presentation
Number:
3581
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Bryant (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), A. Yousuf (Leicester, United Kingdom), R. Cordell (Leicester, United Kingdom), M. Wilde (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), P. Monks (Leicester, United Kingdom). Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients.. 3581
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LC-MS/MS.
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008
Comparison of indirect measurements of multiple breath nitrogen washout with mass spectrometry.
Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions
Year: 2019
Real time mass spectrometric analysis of biomarkers in exhaled breath after exposure to an irritant
Source: International Congress 2019 – Indoor and outdoor air quality considerations
Year: 2019
Methodological issues of sample collection and analysis of exhaled breath
Source: Eur Respir Monogr 2010; 49: 96-114
Year: 2010
Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study
Source: ERJ Open Res, 8 (1) 00493-2021; 10.1183/23120541.00493-2021
Year: 2022
Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Differentialion mobility spectrometry (DMS) for discrimination of local gut infection in exhaled breath
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Comparison of a new nitrogen multiple breath washout method to mass spectrometer SF6 washout in cystic fibrosis subjects
Source: Annual Congress 2011 - Advances in lung function testing from infancy to adulthood
Year: 2011
Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept